COVID-19 Information Read the Latest
Children's Hospital is part of the UPMC family.
Our Sites
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #6 Nationally by U.S. News & World Report.
Through this Children’s Oncology Group (COG) study, researchers are evaluating the drug ABI-009 when used along with two other chemotherapy drugs fight recurrent tumors and tumors that will not respond to standard therapy. ABI-009, also called nanoparticle albumin-bound rapamycin or nab-rapamycin, has shown potential in laboratory tests. It will be given alone and in combination with temozolomide and irinotecan. As a Phase I cancer trial, this program evaluates the effects of the drug on tumors, as well as its side effects and how the body processes it. Researchers also evaluate the highest tolerable dosage level. This study is an initiative of COG’s Pediatric Early Phase Clinical Trial Network of which UPMC Children’s Hospital of Pittsburgh is a part.
Subject to certain exclusion criteria, this study is enrolling participants, ages 12 months to 21 years, who have cancer that has grown or come back after being treated with chemotherapy and/or radiation. Participants may remain in the study unless they develop serious side effects or their tumors worsen. Males and Females: Ages 12 months to 21 years
Participants will be given intravenous (IV) infusions of ABI-009 twice during a 3-week cycle. Starting with the second cycle, ABI-009 will be combined with irinotecan and temozolomide, which will be taken orally on the first 5 days of the cycle. In addition to the IV infusions, study participants will have tests and procedures such as imaging and blood draws, as well as physical examinations at specific intervals. Visits: At least 3 times per 3-week cycle for IV infusions and medical examinations Duration: Open ended
Children’s Oncology Group (ADVL1514) National Cancer Institute
Study Description at National Institutes of Health Cancer and Blood Disorder Research
Jean Tersak, MD
For more information about the study or enrollment, please contact: Andrew Bukowinski MD, MS 412-692-5055
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh One Children’s Hospital Way 4401 Penn Ave. Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.